Secondary metabolites, structure diagram: Trivial name – Tubingensin B

Date: 26 November 2013

  • TubingensinBweb

Prev
Next

Secondary metabolites, structure diagram: Trivial name – Tubingensin B

Copyright: n/a

Notes:

Species: A. tubingensisSystematic name: 1H-7,14b-Ethanobenzo[3,4]cyclohepta[1,2-b]carbazol-1-ol, 2,3,4,4a,5,6,7,9-octahydro-4,4a-dimethyl-7-(1-methylethyl)-, (1a,4a,4aa,7a,14bb)-(-)- (9CI)Molecular formulae: C28H35NOChemical abstracts number: 126663-32-9Selected references: TePaske, Mark R.; Gloer, James B.; Wicklow, Donald T.; Dowd, Patrick F. The structure of tubingensin B: a cytotoxic carbazole alkaloid from the sclerotia of Aspergillus tubingensis. Tetrahedron Letters (1989), 30(44), 5965-8. CODEN: TELEAY ISSN:

Images library

Showing 10 posts of 2574 posts found.

  • Title

    Legend

  • Papular rash with CPA

    Drug rashes: Drug interactions between steroids and anti-fungal drugs – (ecchymosis)

    Image A: Red skin rash on arms due to effect of inhaled steroids termed ecchymosis., Image B: Red skin rash on arms due to effect of inhaled steroids termed ecchymosis., Image C: Papular rash with blisters on the back, associated with CPA but prior to treatment, rash appeared 2 years previously in October 2007. The rash resolved on treatment with azoles., Image D: Papular rash with blisters on the back, associated with CPA but prior to treatment, rash appeared 2 years previously in October 2007. The rash resolved on treatment with azoles.

  • Facial erythema: Side effects of anti-fungal drugs – drug rashes

    Reference: Muco-cutaneous retinoid effects and facial erythema related to the novel triazole antifungal agent voriconazole. Denning, DW & Griffiths, CEM. Clin.Exp Dermatol 2001, 26(8), 648-53.
    Courtesy of Dr D Denning, Wythenshawe Hospital, Manchester.(© Fungal Research Trust)

    Patient AB: Voriconazole rash. Following 8 weeks of Voriconazole, patient had remarkable facial erythema, most consistent with sun exposure because of sparing of her neck., Patient AB: Voriconazole rash. Following 8 weeks of Voriconazole, patient had remarkable facial erythema, most consistent with sun exposure because of sparing of her neck., Patient AB: Discoid lupus erythematosus following 12 months voriconazole therapy. This improved with use of sunblock factor 30 and resolved after discontinuation of voriconazole, 2 months later.

  • Cresemba

    Cresemba (Isavuconazole)

  • Germinating spores of Aspergillus fumigatus

    Germinating spores of Aspergillus fumigatus

  • Aspergillus niger

    Micrographs of A. niger conidia & conidial heads provided by Amaliya Stepanova, Head of Laboratory pathomorphology and cytology at Kashkin Research Institute, Russian Federation.

    A niger conidial head TEM in vitro (РКПГF-1124), A niger mature conidium TEM in vitro (РКПГF-1124)

  • Aspergillus terreus

    Micrographs of A. terreus conidia & conidial heads provided by Amaliya Stepanova, , Head of Laboratory pathomorphology and cytology at Kashkin Research Institute, Russian Federation.

    A terreus aleurospore TEM in vitro (РКПГF-1275), A terreus mature conidium SEM in vitro (РКПГ-1275), A terreus mature conidial head SEM in vitro

  • Electron Microscopy: Aspergillus fumigatus

    Micrographs of A. fumigatus conidia & conidial heads provided by Amaliya Stepanova, , Head of Laboratory pathomorphology and cytology at Kashkin Research Institute, Russian Federation.

    Conidial head (SEM), Part of conidial head (SEM), Mature conidia (SEM), Hyphae (SEM), Murine lung tissue (TEM)

  • Aspergillus clavatus

    Isolate from environmental sample

    A. clavatus, A. clavatus, A. clavatus

  • ABPA complicated by severe varicose bronchiectasis

    Patients has history of ABPA complicating long standing asthma. His total IgE has fluctuated between 2,200 and 4,600 KU/L, his Aspergillus IgE between 36.3 and 65.4 kAU/L and Aspergillus IgG from 87-154 mg/L. He has been taking long term itraconazole.

    December 2012, May 2012, AW CT Dec 2012 2, February 2010

  • Ira F. Salkin 1941-2016

    Ira F. Salkin 1941-2016